USD 5.13
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 0.09 EUR | -71.84% |
2022 | 0.31 EUR | -20.51% |
2021 | 0.39 EUR | -56.67% |
2020 | 0.90 EUR | -1.1% |
2019 | 0.91 EUR | 106.82% |
2018 | 0.44 EUR | -10.2% |
2017 | 0.49 EUR | 22.5% |
2016 | 0.40 EUR | 2.56% |
2015 | 0.39 EUR | 14.71% |
2014 | 0.34 EUR | 36.0% |
2013 | 0.25 EUR | 31.58% |
2012 | 0.19 EUR | 137.5% |
2011 | 0.08 EUR | -65.22% |
2010 | 0.23 EUR | 53.33% |
2009 | 0.15 EUR | 15.38% |
2008 | 0.13 EUR | 45.09% |
2007 | 0.09 EUR | 69.7% |
2006 | 0.05 EUR | 74.26% |
2005 | 0.03 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | 0.03 EUR | -61.77% |
2024 Q2 | 0.02 EUR | -36.51% |
2023 Q2 | 0.09 EUR | 667.31% |
2023 Q3 | 0.04 EUR | -50.4% |
2023 FY | - EUR | -71.84% |
2023 Q1 | -0.02 EUR | 62.32% |
2023 Q4 | 0.08 EUR | 87.7% |
2022 Q1 | - EUR | 100.0% |
2022 FY | - EUR | -20.51% |
2022 Q4 | -0.04 USD | -226.22% |
2022 Q3 | 0.03 EUR | -50.68% |
2022 Q2 | 0.07 EUR | 0.0% |
2021 Q1 | 0.10 EUR | -40.56% |
2021 Q3 | -0.06 EUR | -157.5% |
2021 Q2 | 0.10 EUR | 5.15% |
2021 FY | - EUR | -56.67% |
2021 Q4 | -0.06 USD | 0.0% |
2020 Q3 | 0.21 EUR | 740.0% |
2020 FY | - EUR | -1.1% |
2020 Q1 | 0.14 EUR | -6.67% |
2020 Q2 | 0.02 EUR | -82.14% |
2020 Q4 | 0.16 EUR | -23.81% |
2019 Q2 | 0.13 EUR | 52.94% |
2019 Q4 | 0.15 EUR | 51.67% |
2019 FY | - EUR | 106.82% |
2019 Q1 | 0.08 EUR | -9.38% |
2019 Q3 | 0.10 EUR | -23.92% |
2018 Q2 | 0.13 EUR | 30.0% |
2018 Q1 | 0.10 EUR | -41.18% |
2018 FY | - EUR | -10.2% |
2018 Q3 | 0.11 EUR | -15.38% |
2018 Q4 | 0.09 EUR | -14.73% |
2017 FY | - EUR | 22.5% |
2017 Q4 | 0.17 EUR | 54.55% |
2017 Q3 | 0.11 EUR | 0.0% |
2017 Q2 | 0.11 EUR | 12.13% |
2017 Q1 | 0.10 EUR | -1.9% |
2016 Q1 | 0.09 EUR | -5.76% |
2016 Q2 | 0.10 EUR | 11.11% |
2016 Q3 | 0.11 EUR | 10.0% |
2016 FY | - EUR | 2.56% |
2016 Q4 | 0.10 EUR | -9.09% |
2015 Q3 | 0.10 EUR | 5.26% |
2015 Q1 | 0.10 EUR | 0.11% |
2015 FY | - EUR | 14.71% |
2015 Q2 | 0.10 EUR | 0.0% |
2015 Q4 | 0.10 EUR | -4.5% |
2014 Q4 | 0.09 EUR | 15.03% |
2014 FY | - EUR | 36.0% |
2014 Q3 | 0.08 EUR | 10.0% |
2014 Q2 | 0.08 EUR | -14.29% |
2014 Q1 | 0.09 EUR | 50.09% |
2013 Q4 | 0.06 EUR | -6.72% |
2013 FY | - EUR | 31.58% |
2013 Q1 | 0.07 EUR | 52.37% |
2013 Q2 | 0.07 EUR | 0.0% |
2013 Q3 | 0.06 EUR | -7.41% |
2012 Q3 | 0.05 EUR | 0.0% |
2012 Q2 | 0.05 EUR | -5.0% |
2012 Q1 | 0.05 EUR | 880.39% |
2012 FY | - EUR | 137.5% |
2012 Q4 | 0.04 EUR | -6.74% |
2011 Q3 | 0.02 EUR | 232.87% |
2011 Q4 | 0.01 EUR | -73.16% |
2011 FY | - EUR | -65.22% |
2011 Q1 | 0.04 EUR | 82.3% |
2011 Q2 | -0.01 EUR | -137.53% |
2010 FY | - EUR | 53.33% |
2010 Q4 | 0.02 EUR | -39.77% |
2010 Q3 | 0.03 EUR | 0.0% |
2009 FY | - EUR | 15.38% |
2008 FY | - EUR | 45.09% |
2007 FY | - EUR | 69.7% |
2006 FY | - EUR | 74.26% |
2005 FY | - EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
AstraZeneca PLC | 3.84 USD | 97.727% |
Bristol-Myers Squibb Company PFD CONV 2 | 3.88 USD | 97.75% |
CSPC Pharmaceutical Group Limited | 0.07 USD | -24.714% |
Clarus Therapeutics Holdings, Inc. | -8.04 USD | 101.086% |
Novartis AG | 7.63 USD | 98.856% |
PT Kalbe Farma Tbk. | 0.00 USD | -2138.462% |